Decreased S100-beta protein in schizophrenia: preliminary evidence (2000)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; ELKIS, HELIO - FM
- Unidade: FM
- DOI: 10.1016/s0920-9964(99)00146-2
- Assunto: PSIQUIATRIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Schizophrenia Research
- Volume/Número/Paginação/Ano: v. 43, p. 91-95, 2000
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
GATTAZ, Wagner Farid et al. Decreased S100-beta protein in schizophrenia: preliminary evidence. Schizophrenia Research, v. 43, p. 91-95, 2000Tradução . . Disponível em: https://doi.org/10.1016/s0920-9964(99)00146-2. Acesso em: 04 jun. 2024. -
APA
Gattaz, W. F., Lara, D. R., Elkis, H., Portela, L. V., Gonçalves, C. A., Tort, A. B., et al. (2000). Decreased S100-beta protein in schizophrenia: preliminary evidence. Schizophrenia Research, 43, 91-95. doi:10.1016/s0920-9964(99)00146-2 -
NLM
Gattaz WF, Lara DR, Elkis H, Portela LV, Gonçalves CA, Tort AB, Henna J, Souza DO. Decreased S100-beta protein in schizophrenia: preliminary evidence [Internet]. Schizophrenia Research. 2000 ; 43 91-95.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/s0920-9964(99)00146-2 -
Vancouver
Gattaz WF, Lara DR, Elkis H, Portela LV, Gonçalves CA, Tort AB, Henna J, Souza DO. Decreased S100-beta protein in schizophrenia: preliminary evidence [Internet]. Schizophrenia Research. 2000 ; 43 91-95.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/s0920-9964(99)00146-2 - Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
- Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study
- Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability
- A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia
- Algumas recomendações para estudos com placebo
- Esquizofrenia e gênero
- Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study
- Leonhard´s classification of Schizophrenias and MRI brain abnormalities: preliminary results
- Niacin test in schizophrenia and in major depression
- Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study
Informações sobre o DOI: 10.1016/s0920-9964(99)00146-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas